
Baxter International Inc
BAX · NYSE · Healthcare / Medical Instruments & Supplies
Price History
Full chartMarket Stats
About
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Company Details
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CEOMr. David S. Rosenbloom
- Employees37.50K
- HeadquartersOne Baxter Parkway, Deerfield, IL, United States, 60015, USA
- Websitehttps://www.baxter.com
Leadership
- Mr. David S. RosenbloomExecutive VP & General Counsel · b. 1960
- Ms. Maria SorianoGroup President of Infusion Therapies & Platforms
- Mr. Charles PatelSenior VP & Chief Information Officer · b. 1970
- Mr. Kevin MoranVice President & Head of Investor Relations
- Ms. Stacey EisenSVP, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation
- Ms. Cynthia CarlisleExecutive VP & Chief Human Resources Officer · b. 1975
- Mr. James W. BorziExecutive VP & Chief Supply Chain Officer · b. 1963
- Mr. Steven P. WallacePresident of Advanced Surgery & Commercial Excellence · b. 1980
- Mr. Piero NovelloSenior Vice President and President of International
- Mr. Scott KaplanSenior Vice President of Quality, Regulatory & Patient Safety
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy4
- Buy2
- Hold11
- Strong Sell1
Ownership Breakdown
- Institutions
- 110.22%
- Insiders
- 0.34%
- Retail / Other
- 0.00%
Top Institutional Holders
- BlackRock Inc79.40M15.36%
- Pzena Investment Management, LLC64.53M12.48%
- Dodge & Cox58.39M11.29%
- FMR Inc46.26M8.95%
- Vanguard Capital Management, LLC33.51M6.48%
- Vanguard Portfolio Management, LLC23.99M4.64%
- State Street Corp19.98M3.86%
- Greenhaven Associates Inc14.29M2.76%
- Geode Capital Management, LLC13.76M2.66%
- Amvescap Plc.13.12M2.54%
- Morgan Stanley - Brokerage Accounts7.35M1.42%
Top Fund Holders
- Dodge & Cox Stock I38.62M7.47%
- BlackRock Equity Dividend Instl18.97M3.67%
- Vanguard MStar Total Stk Mkt Idx Invest16.43M3.18%
- Vanguard 500 Index Investor13.72M2.65%
- Vanguard Small Cap Index11.88M2.30%
- Vanguard Windsor Investor Shares10.44M2.02%
- Invesco S&P 500® Equal Weight ETF9.31M1.80%
- Fidelity Series Large Cap Stock8.97M1.74%
- Strategic Advisers Fidelity US TtlStk7.15M1.38%
Dividends
Stock Splits
- Jul 1, 20151841:1000
- May 31, 20012:1
- Dec 1, 1992100000:90823
- Nov 18, 19832:1
- Nov 9, 19812:1